A human serotonin transporter mutation causes constitutive activation of transport activity

Molecular Pharmacology

Volumn 64, Issue 2, 2003, Pages 440-446

  Kilic, Fusun ^a,c   Murphy, Dennis L ^b   Rudnick, Gary ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; COCAINE DERIVATIVE; GUANYLATE CYCLASE; IODINE 125; ISOLEUCINE; N ACETYLPENICILLAMINE; NITRIC OXIDE; OXYHEMOGLOBIN; SEROTONIN; SEROTONIN TRANSPORTER; VALINE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CATALYSIS; CELL STRAIN COS7; HELA CELL; HUMAN; HUMAN CELL; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEROTONIN UPTAKE;

AMINO ACID SUBSTITUTION; ANIMALS; BIOLOGICAL TRANSPORT; BIOTINYLATION; CARRIER PROTEINS; COS CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; ISOLEUCINE; KINETICS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MUTAGENESIS, SITE-DIRECTED; NERVE TISSUE PROTEINS; NITRIC OXIDE DONORS; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TRANSFECTION; VALINE;

EID: 0042343721     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.64.2.440     Document Type: Article

References (33)

1. Adkins EM, Barker EL, and Blakely RD (2001) Interactions of tryptamine derivatives with serotonin transporter species variants implicate transmembrane domain I in substrate recognition. Mol Pharmacol 59:514-523.
2. Anderson G and Horne W (1992) Activators of protein kinase-C decrease serotonin transport in human platelets. Biochim Biophys Acta 1137:331-337.
3. Androutsellis-Theotokis A, Ghassemi F, and Rudnick G (2001) A conformationally sensitive residue on the cytoplasmic surface ofserotonin transporter. J Biol Chem 276:45933-45938.
4. Androutsellis-Theotokis A and Rudnick G (2002) Accessibility and conformational coupling in serotonin transporter predicted internal domains. J Neurosci 22, 8370-8378.
5. 3H]serotonin into rat brain synaptosomes. Jpn J Pharmacol 75:123-128.
6. Barker EL and Blakely RD (1996) Identification of a single amino acid, phenylalanine 586, that is responsible for high-affinity interactions of tricyclic antidepressants with the human serotonin transporter. Mol Pharmacol 50:957-965.
7. Barker EL, Moore KR, Rakhshan F, and Blakely RD (1999) Transmembrane domain I contributes to the permeation pathway for serotonin and ions in the serotonin transporter. J Neurosci 19:4705-4717.
8. Barker EL, Perlman MA, Adkins EM, Houlihan WJ, Pristupa ZB, Niznik HB, and Blakely RD (1998) High affinity recognition of serotonin transporter antagonists defined by species-scanning mutagenesis - an aromatic residue in transmembrane domain I dictates species-selective recognition of citalopram and mazindol. J Biol Chem 273:19459-19468.
9. Bauman AL, Apparsundaram S, Ramamoorthy S, Wadzinski BE, Vaughan RA, and Blakely RD (2000) Cocaine and antidepressant-sensitive biogenic amine transporters exist in regulated complexes with protein phosphatase 2A. J Neurosci 20:7571-7578.
10. Blakely RD, Clark JA, Rudnick G, and Amara SG (1991) Vaccinia-T7 RNA polymerase expression system: evaluation for the expression cloning of plasma membrane transporters. Anal Biochem 194:302-308.
11. Chen JG, Liu-Chen S, and Rudnick G (1998) Determination of external loop topology in the serotonin transporter by site-directed chemical labeling. J Biol Chem 273:12675-12681.
12. Chen JG and Rudnick G (2000) Permeation and gating residues in serotonin transporter. Proc Natl Acad Sci USA 97:1044-1049.
13. Chen JG, Sachpatzidis A, and Rudnick G (1997) The Third transmembrane domain of the serotonin transporter contains residues associated with substrate and cocaine binding. J Biol Chem 272:28321-28327.
14. Collins FS, Brooks LD, and Chakravarti A (1998) A DNA polymorphism discovery resource for research on human genetic variation. Genome Res 8:1229-1231.
15. Cool DR, Leibach FH, Bhalla VB, Mahesh VB, and Ganapathy V (1991) Expression and cyclic AMP-dependent regulation of a high affinity serotonin transporter in the human placental choriocarcinoma cell line (JAR). J Biol Chem 266:15750-15757.
16. Gottardi C, Dunbar L and Caplan M (1995) Biotinylation and assessment of membrane polarity - caveats and methodological concerns. Am J Physiol 37:F285-F295.
17. Harlow E and Lane DP (1988) Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
18. Ignarro LJ, Buga GM, Wood KS, Byrns RE, and Chaudhuri G (1987) Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84, 9265-9269.
19. Jones BJ and Blackburn TP (2002) The medical benefit of 5-HT research. Pharmacol Biochem Behav 71:555-568.
20. Kilic F and Rudnick G (2000) Oligomerization of serotonin transporter and its functional consequences. Proc Natl Acad Sci USA 97:3106-3111.
21. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond) 227:680-685.
22. 3 receptors regulate serotonin transport via nitric oxide and cGMP. J Biol Chem 269:27351-27356.
23. Murphy DL, Andrews AM, Wichems CH, Li Q, Tohda M, and Greenberg B (1998) Brain serotonin neurotransmission: an overview and update with an emphasis on serotonin subsystem heterogeneity, multiple receptors, interactions with other neurotransmitter systems and consequent implications for understanding the actions of serotonergic drugs. J Clin Psychiatry 59 Suppl 15:4-12.
24. Ozaki N, Goldman D, Kaye WH, Plotnikov K, Greenberg BD, Rudnick G, and Murphy DL (2003) A missense mutation in the serotonin transporter is associated with a complex neuropsychiatric phenotype. Mol Psychiatry, in press.
25. Pogun S, Baumann MH, and Kuhar MJ (1994) Nitric oxide inhibits [3H]dopamine uptake. Brain Res 641:83-91.
26. Qian Y, Galli A, Ramamoorthy S, Risso S, DeFelice LJ, and Blakely RD (1997) Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression. J Neurosci 17:45-57.
27. Ramamoorthy S and Blakely RD (1999) Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants. Science (Wash DC) 285:763-766.
28. Ramamoorthy S, Giovanetti E, Qian Y, and Blakely RD (1998) Phosphorylation and regulation of antidepressant-sensitive serotonin transporters. J Biol Chem 273:2458-2466.
29. Ramamoorthy J, Ramamoorthy S, Papapetropoulos A, Catravas J, Leibach F, and Ganapathy V (1995) Cyclic AMP-independent up-regulation of the human serotonin transporter by staurosporine in choriocarcinoma cells. J Biol Chem 270:17189-17195.
30. Sambrook J, Fritsch E, and Maniatis T (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
31. Smicun Y, Campbell SD, Chen MA, Gu H, and Rudnick G (1999) The role of external loop regions in serotonin transport. Loop scanning mutagenesis of the serotonin transporter external domain. J Biol Chem 274:36058-36064.
32. Stahl SM (1998) Mechanism of action of serotonin selective reuptake inhibitors serotonin receptors and pathways mediate therapeutic effects and side effects. J Affect Disord 51:215-235.
33. Towbin H, Staehelin T, and Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354.